Vol 10, No 1 (2024) - Review Article
Pharmacotherapy of non-small cell lung cancer with EGFR activating mutations using tyrosine kinase inhibitors: the role of hospital pharmacists in preventing drug-drug interactions in this class of medicines AbstractPDF (Bulgarian)